Michael Asger Andersen

Also affiliated with Copenhagen University Hospital

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Clinical Outcomes in Patients with Multi-Hit TP53 Chronic Lymphocytic Leukemia Treated with Ibrutinib”.

Clinical Outcomes in Patients with Multi-Hit TP53 Chronic Lymphocytic Leukemia Treated with Ibrutinib

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4890

N/A

1.5DataRank · unranked

40 citations

Kathrine Aarup, Mathias H. Torp, Michael Asger Andersen, Christina W. Yde, Xin Tian +4 more

Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.70071

N/A

0.269DataRank · unranked

5 citations

David W. Hein, Michael Asger Andersen, Arlene B. Chapman, Rhonda M. Cooper‐DeHoff, Zeruesenay Desta +14 more